Oligomerix's Series A Round

Oligomerix raised a round of funding on April 23, 2012.

Oligomerix is a biopharmaceutical company focused on development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers and their newly discovered proteolyti…

Articles about Oligomerix's Series A Round: